The industry continues demonstrating to the world that, despite legal status, cannabis is not immune to the wave of automation we’ve been seeing in recent years; and as such, the industry has even developed its own version of technology known as “cannatech”. The integration of cannatech in the age-old world of cannabis is resulting in cutting-edge technologies that impact nearly every aspect of the industry, including cultivation.
Continue Reading
Category: Trending
The Coachella Valley Music and Arts Festival is stepping into non-fungible token (NFT) technology space, according to the festival’s official Twitter account. Coachella partnered with the crypto exchange FTX US, and the NFTs are minted on the Solana blockchain.
Continue Reading
Credit: Media Relations
Researchers found that synthetic cannabidiol (CBD) augments the anti-viral response of cells to three key proteins produced by the SARS-CoV-2 genome – which was, until now, an unknown effect…
Credit: Kyle Jaeger
U.S. Governors support Cannabis Legalization, using the opportunity to boast marijuana reform accomplishments as part of their annual speech and budget requests. Here are the states with higher fates…
Credit: Audrey Carleton
Cannabidiol—the non-psychoactive cannabis compound better known as CBD—is a potent blocker of SARS-CoV-2 replication in human cells, new research shows. Not only that, but a survey of real-world patients taking prescribed CBD found a “significant” negative relationship between CBD consumption and COVID-19 infection.
Credit: Mashfiq Mizan
Cannabigerolic acid (CBGA) and cannabidiolic acid (CBDA) present in hemp was able to prevent COVID infections, binding onto the SARS-Cov-2 virus’s spike protein, claimed the scientists of Oregon State University…
Credit: Ken Haddad. A study published this week by researchers at Oregon State University found some hemp compounds have the ability to prevent the virus that causes COVID-19 from entering human cells.
Continue Reading
The organization argues that the antiquated 1971 UN Convention on Psychotropic Substances Act is long overdue for some changes. While the Act was created to target drugs that are harmful, ITPRI argues that recent therapeutic evidence and the effectiveness of psilocybin warrants a change in scheduling.
Continue Reading